Positive New Data on Investigational Lemborexant Presented at 32nd Annual SLEEP Meeting

TOKYO and STAMFORD, Conn., June 5, 2018 /PRNewswire/ -- Eisai Co., Ltd. (CEO: Haruo Naito, "Eisai") and Purdue Pharma L.P. (President and CEO: Craig Landau, "Purdue Pharma") today presented the results of two key Phase 1 clinical studies of their investigational sleep/wake...